Follow
Zev A. Binder
Zev A. Binder
Verified email at pennmedicine.upenn.edu
Title
Cited by
Cited by
Year
The genetic landscape of the childhood cancer medulloblastoma
DW Parsons, M Li, X Zhang, S Jones, RJ Leary, JCH Lin, SM Boca, ...
science 331 (6016), 435-439, 2011
8052011
A patient-derived glioblastoma organoid model and biobank recapitulates inter-and intra-tumoral heterogeneity
F Jacob, RD Salinas, DY Zhang, PTT Nguyen, JG Schnoll, SZH Wong, ...
Cell 180 (1), 188-204. e22, 2020
6952020
Long interspersed element-1 protein expression is a hallmark of many human cancers
N Rodić, R Sharma, R Sharma, J Zampella, L Dai, MS Taylor, RH Hruban, ...
The American journal of pathology 184 (5), 1280-1286, 2014
3002014
Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1
S Rathore, H Akbari, M Rozycki, KG Abdullah, MLP Nasrallah, ZA Binder, ...
Scientific reports 8 (1), 5087, 2018
1702018
Epidermal growth factor receptor extracellular domain mutations in glioblastoma present opportunities for clinical imaging and therapeutic development
ZA Binder, AH Thorne, S Bakas, EP Wileyto, M Bilello, H Akbari, ...
Cancer cell 34 (1), 163-177. e7, 2018
1632018
Checkpoint blockade reverses anergy in IL-13Rα2 humanized scFv-based CAR T cells to treat murine and canine gliomas
Y Yin, AC Boesteanu, ZA Binder, C Xu, RA Reid, JL Rodriguez, DR Cook, ...
Molecular Therapy-Oncolytics 11, 20-38, 2018
1522018
Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells
GL Weber, MO Parat, ZA Binder, GL Gallia, GJ Riggins
Oncotarget 2 (11), 833, 2011
1172011
Wnt-mediated endothelial transformation into mesenchymal stem cell–like cells induces chemoresistance in glioblastoma
M Huang, D Zhang, JY Wu, K Xing, E Yeo, C Li, L Zhang, E Holland, ...
Science translational medicine 12 (532), eaay7522, 2020
1042020
Clinical utility of plasma cell-free DNA in adult patients with newly diagnosed glioblastoma: a pilot prospective study
SJ Bagley, SA Nabavizadeh, JJ Mays, JE Till, JB Ware, S Levy, ...
Clinical Cancer Research 26 (2), 397-407, 2020
902020
Exomic sequencing of four rare central nervous system tumor types
C Bettegowda, N Agrawal, Y Jiao, Y Wang, LD Wood, FJ Rodriguez, ...
Oncotarget 4 (4), 572, 2013
802013
Targeting PAK4 to reprogram the vascular microenvironment and improve CAR-T immunotherapy for glioblastoma
W Ma, Y Wang, R Zhang, F Yang, D Zhang, M Huang, L Zhang, JF Dorsey, ...
Nature cancer 2 (1), 83-97, 2021
792021
The role of STAT3 activation in modulating the immune microenvironment of GBM
AP See, JE Han, J Phallen, Z Binder, G Gallia, F Pan, D Jinasena, ...
Journal of neuro-oncology 110, 359-368, 2012
642012
EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma
N Struve, ZA Binder, LF Stead, T Brend, SJ Bagley, C Faulkner, L Ott, ...
Oncogene 39 (15), 3041-3055, 2020
542020
The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics
S Bakas, C Sako, H Akbari, M Bilello, A Sotiras, G Shukla, JD Rudie, ...
Scientific data 9 (1), 453, 2022
532022
Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome
ZA Binder, IM Siu, CG Eberhart, C Ap Rhys, RY Bai, V Staedtke, H Zhang, ...
PloS one 8 (10), e75945, 2013
512013
Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma
I Makhlin, RD Salinas, D Zhang, F Jacob, G Ming, H Song, D Saxena, ...
CNS oncology 8 (3), CNS43, 2019
462019
Case report: prolonged survival following EGFRvIII CAR T cell treatment for recurrent glioblastoma
JS Durgin, F Henderson Jr, MLP Nasrallah, S Mohan, S Wang, SF Lacey, ...
Frontiers in Oncology 11, 669071, 2021
442021
Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumors
Y Yin, JL Rodriguez, N Li, R Thokala, MLP Nasrallah, L Hu, L Zhang, ...
Molecular Therapy 30 (7), 2537-2553, 2022
432022
Single-cell RNA-seq-based proteogenomics identifies glioblastoma-specific transposable elements encoding HLA-I-presented peptides
PE Bonté, YA Arribas, A Merlotti, M Carrascal, JV Zhang, E Zueva, ...
Cell Reports 39 (10), 2022
362022
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma
GL Gallia, M Zhang, Y Ning, MC Haffner, D Batista, ZA Binder, JA Bishop, ...
Nature communications 9 (1), 5410, 2018
362018
The system can't perform the operation now. Try again later.
Articles 1–20